SUPN
USDSupernus Pharmaceuticals Inc. Common Stock
Echtzeitkurs
Kursdiagramm
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$55.430
Hoch
$57.400
Tief
$54.610
Volumen
4.00M
Unternehmensfundamentaldaten
Marktkapitalisierung
3.2B
Branche
Drug Manufacturers - Specialty & Generic
Land
United States
Handelsstatistiken
Durchschnittliches Volumen
0.82M
Börse
NGM
Währung
USD
52-Wochen-Spanne
Ähnliche Nachrichten
B of A Securities Initiates Coverage On Supernus Pharmaceuticals with Buy Rating, Announces Price Target of $65
B of A Securities analyst Pavan Patel initiates coverage on Supernus Pharmaceuticals with a Buy rating and announces Price Target of $65.
TD Cowen Maintains Buy on Supernus Pharmaceuticals, Raises Price Target to $60
TD Cowen analyst Stacy Ku maintains Supernus Pharmaceuticals with a Buy and raises the price target from $45 to $60.
Supernus Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025
ROCKVILLE, Md., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system
Piper Sandler Upgrades Supernus Pharmaceuticals to Overweight, Raises Price Target to $65
Piper Sandler analyst David Amsellem upgrades Supernus Pharmaceuticals from Neutral to Overweight and raises the price target from $40 to $65.
Ähnliche Aktien
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.